Edwards Lifesciences Share Based Compensation Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 136.85  0.24  0.18%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Share Based Compensation of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow from Operations representing the total amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
Share Based Compensation  10 Years Trend  
Increasing
Slightly volatile
 Share Based Compensation 
      Timeline 

Regression Statistics

Arithmetic Mean  41,023,887
Geometric Mean  39,320,976
Coefficient Of Variation  29.70
Mean Deviation  10,852,818
Median  42,100,000
Standard Deviation  12,183,878
Range  30,300,000
R Value  0.97
R Squared  0.94
Significance  0.00000005
Slope  3,031,116

Edwards Lifesciences Share Based Compensation Over Time

2016-12-31  56,900,000 
2017-12-31  56,900,000 
2018-12-31  56,210,526 

Other Fundumenentals

My Equities

My Current Equities and Potential Positions
View AllNext
EW - USA Stock
Edwards Lifesciences Corporation
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
RegionNorth America
ExchangeNew York Stock Exchange
$136.85

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.